Filing Flows › Tenon Medical (TNON) › Q2 2026
Tenon Medical (TNON) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 13, 2026
Tenon Medical (TNON) reported revenue of $1.3M for the second quarter 2026 (Q2 2026), +127% from a year earlier and -7% from the quarter before. Operating margin was -262.2%, net loss $4.0M (316.7% of revenue).
Tenon Medical, Q2 2026: revenue $1.3M (+127% year over year), operating margin -262.2%, net loss $4.0M, operating cash flow −$2.8M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | -7% | +127% |
| Operating profit | −$3.4M | — | — |
| Net earnings | −$4.0M | — | — |
| Operating cash flow | −$2.8M | — | — |
What changed
Revenue was $1.3M in Q2 2026, up 127% year over year and down 7% from the previous quarter.
Gross margin was 63.6%, up 20.2 points from Q2 2025. Operating costs exceeded revenue by $3.4M, an operating margin of -262.2%. Operating expenses grew 34% against revenue growth of 127%. The fastest-growing cost line was Sales & marketing (+67%). The quarter ended with a net loss of $4.0M, wider than the previous quarter's $3.5M loss.
Operating cash flow was −$2.8M. Non-cash charges added back $60K of depreciation and amortization and $412K of share-based compensation. Working capital and other items added $820K. Capital expenditures of $172K exceeded it, leaving free cash flow of −$2.9M.
Questions
What was Tenon Medical's revenue in the second quarter 2026?
Tenon Medical (TNON) reported revenue of $1.3M for the second quarter 2026 (Q2 2026), +127% from a year earlier and -7% from the quarter before.
Was Tenon Medical profitable in the second quarter 2026?
Operating loss was $3.4M (-262.2% of revenue) and net loss $4.0M.
Source: Tenon Medical 10-Q on SEC EDGAR.